AGE AND AGEING-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2021-12-23 ms4000000037027629

投稿命中率:25.0
经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊

281 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2022-11-02 ms7000001176526874

这个under review是不是外审的意思啊

121 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2019-05-11 145dece4m12(暂无昵称)

我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？

404 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2021-12-29 学医的彭于晏

期刊发送的信件里需要注意几个方面的内容？

268 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2021-12-27 MS68862005

什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？

213 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2019-07-10 Uuuuuup

想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表:
投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。

maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。

317 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2019-12-06 12464da8m54(暂无昵称)

已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表:
主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了

183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了

263 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2019-10-02 14635800m23暂无昵称

主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表:
接受没？我也是大修，领导改的面目全非，感觉好玄啊

159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊

230 0

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2019-08-30 12464da8m54(暂无昵称)

接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表:
投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。

maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。

330 0

[GetPortalCommentsPageByObjectIdResponse(id=1083607, encodeId=52f9108360ed9, content=投稿命中率:25.0 经验分享：6.23投，9.10小修，10.9修回，11.7接受，12.21Proof，未见刊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=281, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a5455702520, createdName=ms4000000037027629, createdTime=Thu Dec 23 17:10:00 CST 2021, time=2021-12-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2098028, encodeId=d3ed209802861, content=这个under review是不是外审的意思啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=121, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5c4f6148892, createdName=ms7000001176526874, createdTime=Wed Nov 02 11:09:24 CST 2022, time=2022-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570751, encodeId=23cb5e0751f9, content=我投稿1个多月了还是under review状态，请问这个期刊的一般审稿日期是多久呢？接受率如何？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=404, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=87ff5094725, createdName=145dece4m12(暂无昵称), createdTime=Sat May 11 09:24:00 CST 2019, time=2019-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086283, encodeId=d6741086283ea, content=期刊发送的信件里需要注意几个方面的内容？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=268, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086284, encodeId=02001086284e1, content=什么是期刊编辑的意见和建议？什么是评审/审稿人/reviewer的意见和建议？两者有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=213, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573527, encodeId=ac235e352785, content=想问一下您是什么方向的呀maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=317, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=03282461324, createdName=Uuuuuup, createdTime=Wed Jul 10 00:00:00 CST 2019, time=2019-07-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=581065, encodeId=f4955810657e, content=已经接受了，我是发的脑卒中得183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, beContent=183****9223暂无昵称 2019-10-02 00:00:00 发表: 主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=263, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Dec 06 00:00:00 CST 2019, time=2019-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=577253, encodeId=60485e725361, content=主要看哪些方面啊。准备投这个杂志。之前投age and disease被拒了159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, beContent=159CMYf5254(暂无昵称) 2019-08-30 00:00:00 发表: 接受没？我也是大修，领导改的面目全非，感觉好玄啊, objectType=tool_impact_factor, channel=null, level=null, likeNumber=230, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=3eb45120721, createdName=14635800m23暂无昵称, createdTime=Wed Oct 02 00:00:00 CST 2019, time=2019-10-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=575591, encodeId=d5545e5591b5, content=接受没？我也是大修，领导改的面目全非，感觉好玄啊maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=maomao0807 2019-05-14 00:00:00 发表: 投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, objectType=tool_impact_factor, channel=null, level=null, likeNumber=330, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f62b2484088, createdName=12464da8m54(暂无昵称), createdTime=Fri Aug 30 00:00:00 CST 2019, time=2019-08-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=570931, encodeId=a6b75e0931c4, content=投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=212, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0b681617589, createdName=maomao0807, createdTime=Tue May 14 00:00:00 CST 2019, time=2019-05-14, status=1, ipAttribution=)]

2019-05-14 maomao0807

投稿后45天一审回来了，大修，问题很多很多，很难搞呀。杂志要求挺高的。

212 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务